CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
17.89
+0.11 (0.62%)
Apr 23, 2025, 4:00 PM EDT - Market closed
CareDx Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CareDx stock have an average target of 28.14, with a low estimate of 15 and a high estimate of 40. The average target predicts an increase of 57.29% from the current stock price of 17.89.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CareDx stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $34 → $26 | Strong Buy | Maintains | $34 → $26 | +45.33% | Apr 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $26 → $25 | Hold | Maintains | $26 → $25 | +39.74% | Mar 3, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $40 | Buy | Reiterates | $40 | +123.59% | Feb 27, 2025 |
| Wells Fargo | Wells Fargo | Sell → Hold Upgrades $28 → $24 | Sell → Hold | Upgrades | $28 → $24 | +34.15% | Jan 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $26 | Hold | Reiterates | $26 | +45.33% | Jan 14, 2025 |
Financial Forecast
Revenue This Year
378.11M
from 333.79M
Increased by 13.28%
Revenue Next Year
435.31M
from 378.11M
Increased by 15.13%
EPS This Year
0.62
from 0.93
Decreased by -33.59%
EPS Next Year
1.07
from 0.62
Increased by 72.56%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 392.4M | 463.3M | 526.5M |
| Avg | 378.1M | 435.3M | 502.2M |
| Low | 361.7M | 406.2M | 473.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 17.5% | 22.5% | 21.0% |
| Avg | 13.3% | 15.1% | 15.4% |
| Low | 8.4% | 7.4% | 8.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.75 | 1.49 | 1.85 |
| Avg | 0.62 | 1.07 | 1.49 |
| Low | 0.52 | 0.82 | 1.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -19.8% | 141.4% | 73.4% |
| Avg | -33.6% | 72.6% | 39.7% |
| Low | -43.8% | 33.3% | 6.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.